Dr. Jason J Lee (이주헌)

Chicago Born. Canadian. Korean.
Rheumatologist. Internist.
MD/PhD Scientist in Vascular Biology, Scleroderma, Vasculitis, Clinical Pharmacology. Vanier Scholar.

[Dr. Jason J Lee (이주헌) @DocJasonLee]

All contents, including retweets, likes and/or linked materials, are not intended and should not be viewed as medical advice nor any form of doctor-patient relationship. Contents are for interest only and have no relation to those of any academic, hospital, or other institution🚩

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@JoannaStern @bee__computer @panos_panay I used to think Apple was going to untouchable in this space of health tech (wearables + AI), but now everyone else is catching up and pulling ahead. Wasted opportunity for Apple, Good for Amazon/Google/Microsoft/possibly X. #LoveJoannaSternStories

[Dr. Jason J Lee (이주헌) @DocJasonLee]

Dear Canadian Rheumatology/Autoimmunity Community 🇨🇦,

Welcome to https://t.co/z7WwWjkGNK! Join us and spread the word. #SharingIsCaring

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@CMA_Docs @CRASCRRheum @PierrePoilievre @MarkJCarney This article is a good conversation starter, but only scratches the surface! We should be advocating not just for our pharmacy colleagues, but also our burnt out MD colleagues and most importantly our patients who are affected by this in many ways!

[Dr. Jason J Lee (이주헌) @DocJasonLee]

Competition Bureau investigating Express Scripts practices in pharmacy sector /via @globeandmail https://t.co/ZKtCznNyEK

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@CMA_Docs @CRASCRRheum @PierrePoilievre @MarkJCarney This is a huge and GROWING problem for all immunology patients in Canada with autoimmune diseases on life saving advanced therapies. Rheumatologists and other immunology specialties feel the pain and burden of PBMs every day.

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@Janetbirdope @RheumNow @ACRheum Assuming your MDA5 patient even survives! Very few, if any, MDA5 patients in Canada have survived their disease without lung transplant - and that’s just the beginning of their treatment journey. #ScaryDisease

[Dr. Jason J Lee (이주헌) @DocJasonLee]

I agree this is big business - some good, mostly bad. My question: what is a “Longevity Specialist”? NOT a royal college recognized specialty in Canada. I have a PhD in Sirtuin biology and follow ⁦@PeterAttiaMD⁩. Can I be a “Longevity Specialist”? https://t.co/bgjUfF5mYj

[Dr. Jason J Lee (이주헌) @DocJasonLee]

Excited to be co-moderating the #ACR24 Great Debate today with Dr. Laura Cappelli!

Shout out to poster 0210 by Dr. Rob Valdovinos et al. - Just as excited to be representing the 2nd straight ACR with a Korean-American on the main podium!

[American College of Rheumatology @ACRheum]

#ACR24 Preview: Experts will untangle the complexities of mixed connective tissue disease in this year's Great Debate. Read more in ACR Convergence Today → https://t.co/Y6U5FKRGTh

[American College of Rheumatology @ACRheum]

#ACR24 Preview: Experts will untangle the complexities of mixed connective tissue disease in this year's Great Debate. Read more in ACR Convergence Today → https://t.co/Y6U5FKRGTh

[American College of Rheumatology @ACRheum]

ACR Convergence 2024 Great Debate – MCTD: Is It Just Letters? Let us know where you stand before our excellent teams face off in the #ACR24 Great Debate!

Do you believe that mixed connective tissue disease (MCTD) is a distinct disease entity?

[Dr. Jason J Lee (이주헌) @DocJasonLee]

Is it just me? I feel like my #rheumatology patients are flaring more and overall less stable than ever before!

Hoping @RheumNow can help ask this question to a broader audience: are your patients less stable this year? And are you feeling more burned out as a result?

[Dr. Jason J Lee (이주헌) @DocJasonLee]

Opinion: Apple’s AI strategy is long term and focused on health care, not in search or party tricks. The only way @Apple doesn’t become the biggest global healthcare corporation in 10 years is if ⁦@elonmusk⁩ realizes he can beat Apple+OpenAI with X. https://t.co/fgwyElNb8P

[Amanda Grant-Orser @agrantorser]

🔥Patients with ILD experience delays in diagnosis. We interviewed patients and physicians to help understand why.

We need to advocate for:

- increased ILD awareness and education
-access to chest imaging
-earlier referral to respirology

https://t.co/ZWkj8x8QwR
#curePF

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@Janetbirdope @SchulichMedDent Wow! Congrats Andreu and team! Looking forward to seeing what looks like impressive data (and hope) for SSc patients!

[Dr. Jason J Lee (이주헌) @DocJasonLee]

Shout out to @RheumNow, @Janetbirdope, @drdavidliew, and @EBRheum for amazing coverage of #ACR23! I am sad to be missing it in person, but have my finger on the pulse of Rheumatology this year via these savvy experts. Thank you!

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@SindhuJohnson5 @AboabatAos @UofTRheum @SchroederInst @SinaiHealth @CRASCRRheum Amazing to see more (and much needed) Canadian SSc experts train and graduate! All owed to World Class mentors like @SindhuJohnson5!

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@Janetbirdope Love the PowerPoint slide design. Looks like ECP isn't going to make it on this year's EULAR guidelines. Wonder if it will get a mention?

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@Janetbirdope @RheumNow @eular_org Yes, especially in early disease or active/progressive late disease (and definitely with active dilated capillaries)

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@Janetbirdope @RheumNow @eular_org When are we going to have a CRA/CSRG Canadian national guidelines?

[Dr. Jason J Lee (이주헌) @DocJasonLee]

@RheumNow Rheumatology is blessed with so many amazing women leaders. So Hard to pick just 25! "Snubs" are inevitable when lists like these are created. For Canadian rheumatology, this list is incomplete without @Janetbirdope, an important international mentor/collaborator for many. IMO